Gerald D. Cagle, Director at Clearside Biomedical, Inc. (CLSD), bought 5,000 shares at $7.08 ($35K) on 2017-08-11, disclosed to the SEC on 2017-08-15.
Open-market purchase of $35k CLSD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| AERI | BUY | 2018-05-25 | $49K | — | Filing → |
| AERI | BUY | 2018-05-22 | $50K | — | Filing → |
| CLSD | BUY | 2018-03-23 | $89K | — | Filing → |